Cargando…
Cardiac-targeted delivery of regulatory RNA molecules and genes for the treatment of heart failure
Ribonucleic acid (RNA) in its many facets of structure and function is becoming more fully understood, and, therefore, it is possible to design and use RNAs as valuable tools in molecular biology and medicine. Understanding of the role of RNAs within the cell has changed dramatically during the past...
Autores principales: | Poller, Wolfgang, Hajjar, Roger, Schultheiss, Heinz-Peter, Fechner, Henry |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2868179/ https://www.ncbi.nlm.nih.gov/pubmed/20176815 http://dx.doi.org/10.1093/cvr/cvq056 |
Ejemplares similares
-
New Therapeutics Targets in Chronic Viral Cardiomyopathy
por: Poller, W., et al.
Publicado: (2006) -
RNA Interference and MicroRNA Modulation for the Treatment of Cardiac Disorders: Status and Challenges
por: Poller, W., et al.
Publicado: (2008) -
Pharmacological and Biological Antiviral Therapeutics for Cardiac Coxsackievirus Infections
por: Fechner, Henry, et al.
Publicado: (2011) -
Multimodality Imaging Reveals Divergent Responses of Left and Right Heart to Treatment in Cardiac Amyloidosis
por: Poller, Wolfgang, et al.
Publicado: (2019) -
Coxsackievirus B3 and adenovirus infections of cardiac cells are efficiently inhibited by vector-mediated RNA interference targeting their common receptor
por: Fechner, H, et al.
Publicado: (2007)